EUVIMEDEUVIMED entdecken
Open Access

Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda

Phyllis Awor iD, Romain Coppée iD, Nimol Khim, Laurine Rondepierre, Camille Roesch iD, Chanra Khean, Chanvong Kul, Rotha Eam, Thornleaksmey Lorn, Proscovia Athieno, Joseph Kimera iD, Betty Balikagala und 11 weitere

Antimicrobial Agents and Chemotherapy · 07.08.2024 · 68 (8)

DOI: 10.1128/aac.01659-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 07.08.2024. Verfasst von Phyllis Awor und 22 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Plasmodium falciparum, Artemisinins, Antimalarials, Malaria, Falciparum. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, Unitaid, Agence Nationale de la Recherche (ANR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Artemisinin-based combination therapies (ACTs) were introduced as the standard of care for uncomplicated malaria in Africa almost two decades ago. Recent studies in East Africa have reported a gradual increase in kelch13 ( k13 ) mutant parasites associated with reduced artesunate efficacy. As part of the Community Access to Rectal Artesunate for Malaria project, we collected blood samples from 697 children with signs of severe malaria in northern Uganda between 2018 and 2020, before and after the introduction of rectal artesunate (RAS) in 2019. K13 polymorphisms were assessed, and parasite editing and phenotyping were performed to assess the impact of mutations on parasite resistance. Whole-genome sequencing was performed, and haplotype networks were constructed to determine the geographic origin of k13 mutations. Of the 697 children, 540 were positive for Plasmodium falciparum malaria by PCR and were treated with either RAS or injectable artesunate monotherapy followed in most cases by ACT. The most common k13 mutation was C469Y (6.7%), which was detected more frequently in samples collected after RAS introduction. Genome editing confirmed reduced in vitro susceptibility to artemisinin in C469Y-harboring parasites compared to wild-type controls ( P < 0.001). The haplotypic network showed that flanking regions of the C469Y mutation shared the same African genetic background, suggesting a single and indigenous origin of the mutation. Our data provide evidence of selection for the artemisinin-resistant C469Y mutation. The realistic threat of multiresistant parasites emerging in Africa should encourage careful monitoring of the efficacy of artemisinin derivatives and strict adherence to ACT treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumArtemisininsAntimalarialsMalaria, FalciparumDrug ResistanceProtozoan ProteinsUgandaHumansMutationArtesunateChild, PreschoolChildMaleFemale

Stichwörter der Autor:innen

Ugandaartemisinin resistancek13malariarectal artesunate

Substanzen

ArtemisininsAntimalarialsProtozoan ProteinsartemisininArtesunate

Autor:innen und Institutionen

  • School of Public Health, Makerere University, Kampala, Uganda.
  • Laboratoire de parasitologie-mycologie, UR 7510 ESCAPE, Université de Rouen Normandie, Rouen, France.
  • Malaria Research Unit, Institut Pasteur in Cambodia, Phnom Penh, Cambodia.
  • MERIT, IRD, Université Paris Cité, Paris, France.
  • Department of Tropical Medicine and Parasitology, School of Medicine, Juntendo University, Tokyo, Japan.
  • Faculty of Medicine, Gulu University, Gulu, Uganda.

ORCID-Profile: Phyllis Awor, Romain Coppée, Camille Roesch, Joseph Kimera, Aita Signorell, Christian Lengeler, Christian Burri, Manuel W Hetzel, Benoit Witkowski

Förderung

  • World Health Organization
  • Unitaid
  • Agence Nationale de la Recherche (ANR)

Zitieren

APA

Awor, P., Coppée, R., Khim, N., Rondepierre, L., Roesch, C., Khean, C., Kul, C., Eam, R., Lorn, T., Athieno, P., Kimera, J., Balikagala, B., Odongo-Aginya, E. I., Anywar, D. A., Mita, T., Clain, J., Ringwald, P., Signorell, A., Lengeler, C., …, & Witkowski, B. (2024). Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda. Antimicrobial Agents and Chemotherapy, 68(8). https://doi.org/10.1128/aac.01659-23

Vancouver

Awor P, Coppée R, Khim N, Rondepierre L, Roesch C, Khean C, et al. Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda. Antimicrobial Agents and Chemotherapy. 2024;68(8). doi:10.1128/aac.01659-23

BibTeX
@article{Awor2024,
  author = {Awor, Phyllis and Coppée, Romain and Khim, Nimol and Rondepierre, Laurine and Roesch, Camille and Khean, Chanra and Kul, Chanvong and Eam, Rotha and Lorn, Thornleaksmey and Athieno, Proscovia and Kimera, Joseph and Balikagala, Betty and Odongo-Aginya, Emmanuel I and Anywar, Denis A and Mita, Toshihiro and Clain, Jérôme and Ringwald, Pascal and Signorell, Aita and Lengeler, Christian and Burri, Christian and Ariey, Frédéric and Hetzel, Manuel W and Witkowski, Benoit},
  title = {Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  volume = {68},
  number = {8},
  doi = {10.1128/aac.01659-23}
}
Kostenlos starten →